Aug 4, 2026 04:33PM
Aug 4, 2026 04:01PM
Aug 4, 2026 04:01PM
Aug 1, 2026 10:00AM
Jul 21, 2026 04:05PM
Jul 6, 2026 05:41AM
May 11, 2026 08:42AM RBC Capital on Gilead Sciences (GILD): 'What To Look For In Upcoming UC Readout'
May 7, 2026 04:07PM
May 7, 2026 04:01PM
Apr 28, 2026 08:45AM
Apr 28, 2026 08:45AM
Apr 22, 2026 04:05PM
Apr 14, 2026 12:03PM
Apr 14, 2026 12:00PM PEPFAR and The Global Fund Make Additional Investment in Gilead’s Lenacapavir for HIV Prevention to Further Expand Access
Feb 23, 2026 06:01AM
Feb 23, 2026 06:01AM
Feb 20, 2026 07:58AM
Feb 11, 2026 09:27AM
Feb 11, 2026 07:09AM
Feb 11, 2026 05:08AM
Feb 11, 2026 05:04AM Goldman Sachs Reiterates Neutral Rating on Gilead Sciences (GILD)
Feb 10, 2026 04:03PM
Feb 10, 2026 04:01PM
Jan 30, 2026 06:28AM
Jan 27, 2026 04:05PM
Jan 8, 2026 08:49AM
Jan 7, 2026 03:03AM
Dec 22, 2025 08:02AM Gilead exercises option for Assembly Bio's herpes treatment programs
Dec 22, 2025 08:00AM
Dec 12, 2025 10:31AM
Nov 16, 2025 03:00PM
Nov 3, 2025 07:12AM
Oct 30, 2025 04:47PM
Oct 30, 2025 04:04PM
Oct 30, 2025 04:02PM Gilead Sciences Announces Third Quarter 2025 Financial Results
Oct 12, 2025 03:00PM
Oct 9, 2025 04:05PM
Sep 4, 2025 02:15PM
Sep 4, 2025 02:15PM
Aug 21, 2025 08:30AM
Aug 11, 2025 06:00PM
Aug 7, 2025 04:25PM Gilead posts flat second quarter profit, ups full-year outlook on strong HIV sales
Aug 7, 2025 04:23PM
Aug 7, 2025 04:02PM
Jul 24, 2025 04:05PM
Jul 20, 2025 08:00PM
Jul 14, 2025 09:31AM
Jul 14, 2025 09:30AM
Jul 9, 2025 08:00AM Gilead Finalizes Agreement With the Global Fund to Accelerate Access to Twice-Yearly Lenacapavir for HIV Prevention for up to Two Million People in Primarily Low- and Lower-Middle-Income Countries
Jun 25, 2025 07:02AM

1,219,509 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All